Her group's main interests include transcriptional and epigenetic regulation of gene expression in cancer and discovering new small molecules to modulate this process. Her publications in this area include several papers on the establishment and use of a cell-based system for epigenetic drug screens and the characterization of HDAC inhibitors as well as more recent studies on Jumonji demethylase inhibitors.